proprietary in-licensing capabilities
Licensing, Mergers & Acquisitions
Geller Biopharm has successfully executed reverse merger transactions for its clients.
The ideal reverse merger combines a private company with an exciting product and/or platform with a public company with cash or trading near or below cash.
A reverse merger can also target a non-biotech company or "Form 10" shell with no cash, along with concomitant financing.
Traditionally, reverse mergers have been viewed somewhat negatively, compared to IPO's, however, their image has improved. Cougar has demonstrated that reverse mergers can be highly successful.
Overall, this is a viable strategy, especially in a period when the IPO window is closed.
Get our newsletter
Sign up for our email list
Download our presentation
Get a digital copy of our PDF presentation